Dongsheng Huang
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 23
- Cancer, Hypoxia, and Metabolism 13
- MicroRNA in disease regulation 11
- Molecular Biology top 5%
- RNA modifications and cancer 19
- Ubiquitin and proteasome pathways 10
- Circular RNAs in diseases 9
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 8
- Immunology top 5%
- Molecular Medicine top 5%
-
- Autophagy in Disease and Therapy 8
- Journals
- Advanced Materials (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Dongsheng Huang
92 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 134
- Cancer Research 1.2k
- Molecular Biology 2.0k
- Oncology 619
- Immunology 430
- Molecular Medicine 99
Countries citing papers authored by Dongsheng Huang
This map shows the geographic impact of Dongsheng Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongsheng Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongsheng Huang more than expected).
Fields of papers citing papers by Dongsheng Huang
This network shows the impact of papers produced by Dongsheng Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongsheng Huang. The network helps show where Dongsheng Huang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dongsheng Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 68 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 17 | |
| 10 | High Expression of lncRNA HEIH is Helpful in the Diagnosis of Non-Small Cell Lung Cancer and Predicts Poor Prognosis | 2022 | 10 |
| 11 | 2021 | 1 | |
| 12 | 2020 | 12 | |
| 13 | 2020 | 43 | |
| 14 | 2020 | 35 | |
| 15 | 2019 | 28 | |
| 16 | 2019 | 36 | |
| 17 | 2018 | 30 | |
| 18 | 2018 | 16 | |
| 19 | 2015 | 29 | |
| 20 | 2015 | 9 |
About Dongsheng Huang
Dongsheng Huang is a scholar working on Cancer Research, Molecular Biology and Hepatology, having authored 95 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (23 papers), RNA modifications and cancer (19 papers), Cancer, Hypoxia, and Metabolism (13 papers), MicroRNA in disease regulation (11 papers), Ubiquitin and proteasome pathways (10 papers), Circular RNAs in diseases (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Autophagy in Disease and Therapy (8 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (2.0k citations) and Oncology (619 citations). Dongsheng Huang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Qiuran Xu, Liu Yang, Meihua Sui, Weilei Hu, Xiaodong Sun, Guosheng Wang, Yibing Xu, Xiaoge Hu, Jiahong Jiang and Yang Guo. Their work appears in journals such as Advanced Materials, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.